Biorelevant In Vitro Skin Permeation Testing and In Vivo Pharmacokinetic Characterization of Lidocaine from a Nonaqueous Drug-in-Matrix Topical System
Open Access
- 12 August 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in AAPS PharmSciTech
- Vol. 22 (6), 1-10
- https://doi.org/10.1208/s12249-021-02101-y
Abstract
Recently, lidocaine topical systems utilizing nonaqueous matrices have been developed and provide efficient lidocaine delivery through the skin, such that lower concentrations of drug provide equivalent or greater drug delivery than drug-in-matrix hydrogel lidocaine patches. This study characterizes drug delivery from a nonaqueous lidocaine topical system with increasing drug load both in vitro and in vivo. Topical systems formulated with either 1.8% or 5.4% lidocaine were applied to healthy volunteers’ backs (n = 15) for 12 h in a single-center, open-label, four-treatment, four-period crossover pharmacokinetic study. Subjects were dosed with either three 1.8% systems or one, two, or three 5.4% systems in each period. Blood was collected for up to 48 h, and plasma lidocaine levels were measured with a validated HPLC method. In parallel, human and mouse skin models characterized the in vitro skin permeation profile. The pharmacokinetic profile was linear between one, two, and three lidocaine 5.4% applications. Application of three lidocaine 1.8% systems (108 mg lidocaine) was bioequivalent to one lidocaine 5.4% system (108 mg lidocaine). Both topical systems remained well adhered to the skin and irritation was mild. The 5.4% system had approximately threefold higher skin permeability than the 1.8% system in the mouse and human skin models. The results indicate increasing the drug load by three times results in triple the drug delivery both in vivo and in vitro. The relationship between the in vitro permeation and in vivo absorption correlates and is nonlinear.Keywords
This publication has 21 references indexed in Scilit:
- Pharmacokinetics and pharmacodynamics of lignocaine: A reviewWorld Journal of Anesthesiology, 2015
- Lidocaine patch (5%) produces a selective, but incomplete block of Aδ and C fibersPain, 2012
- Challenges and opportunities in dermal/transdermal deliveryTherapeutic Delivery, 2010
- The effects of some permeability enhancers on the percutaneous absorption of lidocaine.2010
- Physicochemical and pharmacokinetic parameters in drug selection and loading for transdermal drug deliveryIndian Journal of Pharmaceutical Sciences, 2008
- Dermal and Transdermal Drug Delivery Systems: Current and Future ProspectsDrug Delivery, 2006
- Structure of the skin barrier and its modulation by vesicular formulationsProgress in Lipid Research, 2003
- The pharmacokinetics of lignocaine in humans during a computer‐controlled infusionEuropean Journal of Pain Supplements, 1997
- Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgiaPain, 1996
- Skin permeability of various non-steroidal anti-inflammatory drugs in manLife Sciences, 1986